Total Visits

Views
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.116

Total Visits Per Month

April 2021May 2021June 2021July 2021August 2021September 2021October 2021
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.2241222

File Downloads

Views
Manuscript 20170801.docx77
Supplementary Material 20170801.docx6

Top country views

Views
United States54
Germany12
China11
United Kingdom10
France6
Czech Republic5
Singapore3
Canada2
Ecuador2
Sweden2

Top cities views

Views
Ashburn30
Fairfield8
Oakland8
Beijing4
Calgary1
Changi1
Dublin1
Edmonton1
Fuzhou1
Guangzhou1